Journal of Hepatology
Volume 51, Issue 5 , Pages 874-880 , November 2009

Outcomes of patients with hepatitis C undergoing simultaneous liver–kidney transplantation

  • Lisa B. Van Wagner

      Affiliations

    • Division of Hepatology, Medicine Northwestern University, Chicago, IL, USA
    • ,
  • Talia Baker

      Affiliations

    • Division of Organ Transplantation, Medicine Northwestern University, Feinberg School of Medicine, 675 N St. Clair St., Chicago, IL 60611, USA
    • ,
  • Shubhada N. Ahya

      Affiliations

    • Division of Nephrology, Medicine Northwestern University, Chicago, IL, USA
    • ,
  • John P. Norvell

      Affiliations

    • Division of Hepatology, Medicine Northwestern University, Chicago, IL, USA
    • ,
  • Edward Wang

      Affiliations

    • Division of Organ Transplantation, Medicine Northwestern University, Feinberg School of Medicine, 675 N St. Clair St., Chicago, IL 60611, USA
    • Division of Preventive Medicine Northwestern University, Chicago, IL, USA
    • ,
  • Josh Levitsky

      Affiliations

    • Division of Hepatology, Medicine Northwestern University, Chicago, IL, USA
    • Division of Organ Transplantation, Medicine Northwestern University, Feinberg School of Medicine, 675 N St. Clair St., Chicago, IL 60611, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 312 6954413; fax: +1 312 6950036.

Received 19 March 2009 ,Revised 5 May 2009 ,Accepted 27 May 2009.

References 

  1. Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, et al. Declining outcomes in simultaneous liver–kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation. 2008;85:935–942
  2. Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, et al. Simultaneous liver–kidney transplantation: evaluation to decision making. Am J Transplant. 2007;7:1702–1709
  3. Yoo HY, Thuluvath PJ. Short-term post liver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int. 2005;25:536–541
  4. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant. 2006;6:2651–2659
  5. Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl. 2005;11:1048–1055
  6. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl. 2002;8:916–921
  7. Marik PE, Wood K, Starzl TE. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant. 2006;21:478–482
  8. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl. 2003;9:741–747
  9. Thompson JA, Lake JR. Review of hepatitis C in liver transplantation. Transplantation Updates. 2008;2:3–12
  10. Guitard J, Ribes D, Kamar N, Cointault O, Lavayssiere L, Esposito L, et al. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail. 2006;28:419–425
  11. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–940
  12. Yoo H, Thuluvath P. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation. 2002;7:1007–1012
  13. Delgado-Borrego A, Casson D, Schoenfeld D, Somsouk M, Terelia A, Jordan SH, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004;77:703–710
  14. Saliba F, Lakehal M, Pageaux G-P, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13:136–144
  15. Thervet E, Pol S, Legendre C, Gagnadoux M, Cavalcanti R, Kreis H. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation. 1994;58:625–628
  16. Magnone M, Holley JL, Shapiro R, Scantelbury V, McCauley J, Jordan M, et al. Interferon-alpha-induced acute renal allograft rejection. Transplantation. 1995;59:1068–1070
  17. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995;59:1426–1431
  18. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier H, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron. 1996;74:512–516
  19. Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, et al. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003;3:74–78
  20. Rostaing L. Treatment of hepatitis C virus infection after renal transplantation: new insights. Nephrol Dial Transplant. 2000;15(Suppl 8):S74–S76
  21. Kamar N, Ribes D, Izopet J, Rostaing L. Treatment of hepatitis C virus infection after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation. 2006;82:853–856
  22. Mukherjee S, Ariyarantha K. Successful eradication of recurrent HCV with preservation of renal function in a liver–kidney transplant recipient with pegylated interferon and ribavirin. Transplantation. 2007;84:1374–1375
  23. Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, Strazzabosco M. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. J Clin Gastroenterol. 2007;41:216–220
  24. Schmitz V, Kiessling A, Bahra M, Puhl G, Kahl A, Berg T, et al. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation. Ann Transplant. 2007;12:22–27
  25. METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy in chronic hepatitis C. Hepatology 1994;20:15–20.
  26. Port FK, Bragg-Gresham JL, Metzger RA, Dykstra DM, Gillespie BW, Young EW, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002;74:1281–1286
  27. Durlik M, Gaciong Z, Rowinska D, Rancewicz Z, Lewandowska D, Kozlowska B, et al. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transpl Int. 1998;11(Suppl 1):S135–S139
  28. Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg. 2006;141:735–742
  29. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver–kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation. 2003;76:348–353
  30. Calne RY, Davis DR, Hadjiyannakis E, Sells RA, White D, Herbertson BM, et al. Immunosuppressive effects of soluble cell membrane fractions, donor blood and serum on renal allograft survival. Nature. 1970;227:903–906
  31. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation. 1995;59:919–921
  32. Opelz G, Margreiter R, Dohler B. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation. 2002;74:1390–1394
  33. Audard V, Matignon M, Dahan K, Lang P, Grimbert P. Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview. Transpl Int. 2008;21:11–17
  34. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, et al. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transpl. 2008;8:2618–2626
  35. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transpl. 2008;8:2243–2251

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00394-8

doi: 10.1016/j.jhep.2009.05.025

Journal of Hepatology
Volume 51, Issue 5 , Pages 874-880 , November 2009

Article Tools

* Image Usage & Resolution